医薬品原薬中の類縁物質・微量不純物
API製造時に発生する不純物です。
ジェネリック薬を新たに開発する際、先発品と類縁物質(不純物)の上限規定も同等にする必要になります。その測定・管理に必要な標準物質になります。
当品目は、弊社にて日本向けの代理店を行っいる Clearsynth Lab より供給させていただきます。
当社は、医薬品開発、あるいは品質管理に必要な各種標準物質の専門メーカーです。
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 | 14
| Riluzole-N-Methyl Analogue |
| CAS No.: |
133840-97-8 1744-22-5 |
 |
| Formula: |
C9H7F3N2OS |
| Controlled Substance: |
False |
| Details: |
Neuroprotective |
| R-isomer of Montelukast Diol intermediate |
| CAS No.: |
142542-48-1 |
 |
| Formula: |
- |
| Controlled Substance: |
False |
| Details: |
Antiasthmatic |
| S-(-)-Lansoprazole |
| CAS No.: |
138530-95-7 |
 |
| Formula: |
- |
| Controlled Substance: |
False |
| Details: |
Antiulcerative |
| S-(-)-p-Chlorowarfarin |
| CAS No.: |
70888-76-5 |
 |
| Formula: |
C19H15C1O4 |
| Controlled Substance: |
False |
| Details: |
Rodenticide |
| S-(+)-Desmethyl Mephenytoin |
| CAS No.: |
65567-34-2 |
 |
| Formula: |
C11H12N2O2 |
| Controlled Substance: |
False |
| Details: |
Anticonvulsant |
| Sildenafil-N-Ethyl Analogue |
| CAS No.: |
642928-07-2 |
 |
| Formula: |
C23H32N6O4S |
| Controlled Substance: |
False |
| Details: |
Antihypertensive; In treatment of male erectile dysfunction |
| Sulfo-Ciprofloxacin |
| CAS No.: |
105093-21-8 85721-33-1 |
 |
| Formula: |
C17H18FN3O6S |
| Controlled Substance: |
False |
| Details: |
Antibacterial |
| Tamsulosin propyl-Analogue HCl |
| CAS No.: |
- |
 |
| Formula: |
C21H30N2O5S |
| Controlled Substance: |
False |
| Details: |
Treatment of benign prostatic hypertrophy |
| Tianeptine-MC5 |
| CAS No.: |
104732-22-1 |
 |
| Formula: |
C19H21C1N2O4S |
| Controlled Substance: |
False |
| Details: |
Antidepressant |
| Topiramate-D-Galactopyranose analogue |
| CAS No.: |
97240-79-4 |
 |
| Formula: |
C12H21NO8S |
| Controlled Substance: |
False |
| Details: |
Anticonvulsant; antimigraine. |
| Zonisamide Analogue: 5-Fluoro-3-sulfamoyl methyl-1,2-benzisoxazole |
| CAS No.: |
68291-97-4 |
 |
| Formula: |
C8H5FNO4S |
| Controlled Substance: |
False |
| Details: |
Anticonvulsant |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 | 14